RxDoctor Payments Data

Thu Trinh

Family · Rancho Mirage, CANPI 1942731187

Payments from drug & device makers

$18,961in general payments, 2019–2025

Across 652 payments — averaging $29.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novartis$1K
  • Johnson & Johnson$984
  • Sobi, Inc$829
  • Gilead$791
  • Pfizer$768
  • plus $13K from 54 others

What the payments were for

  • Food & beverage$17,71793%
  • Education$1,2457%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)37$1,312
Novartis64$1,216
Johnson & Johnson28$984
Sobi, Inc18$829
Gilead14$791
Pfizer29$768
Merck32$757
Seagen Inc.26$736
Takeda Pharmaceuticals U.S.A., Inc.24$694
Incyte Corporation22$673
Eisai Inc.18$569
AbbVie10$534
Amgen19$519
Lilly USA, LLC22$515
Astellas Pharma US Inc15$410
E.r. Squibb & Sons, L.L.C.27$401
Puma Biotechnology, Inc.12$399
Daiichi Sankyo Inc.11$374
Bayer11$374
Blueprint Medicines Corporation8$330
Rigel Pharmaceuticals, Inc.10$312
Beigene USA, Inc.11$286
Genentech USA, Inc.7$270
Bristol Myers Squibb11$262
Boehringer Ingelheim9$246
GSK3$246
Karyopharm Therapeutics Inc.8$236
Sanofi5$193
Beone Medicines USA, Inc.6$188
Genmab U.S., Inc.6$182
Coherus Oncology, Inc.6$173
Ipsen Biopharmaceuticals, Inc8$167
Array Biopharma Inc12$166
Regeneron Healthcare Solutions, Inc.5$162
Galvanize Therapeutics, Inc1$158
Tempus AI, Inc6$157
Sanofi-aventis U.S. LLC2$155
Tersera Therapeutics LLC4$153
Pharmacyclics LLC, An Abbvie Company7$145
AVEO Pharmaceuticals, Inc.6$135
CSL Behring6$119
Deciphera Pharmaceuticals Inc.5$118
Taiho Oncology, Inc.4$111
Dendreon Pharmaceuticals LLC4$107
Stemline Therapeutics Inc.4$101
EMD Serono, Inc.5$98
G1 Therapeutics, Inc.1$96
Kyowa Kirin, Inc.5$92
Immunocore Limited1$88
Recordati_rare_diseases_inc.4$85
Iovance Biotherapeutics, Inc.3$83
Foundation Medicine, Inc.4$75
Morphosys, US Inc.3$71
Pharmaessentia USA Corporation2$69
Mirati Therapeutics, Inc.3$56
Progenics Pharmaceuticals, Inc.2$56
Legend Biotech USA Inc.2$55
Agios Pharmaceuticals, Inc.2$38
Servier Pharmaceuticals LLC1$31
ADC Therapeutics America, Inc.2$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,961 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Medicare billing

Part B allowed, 2024
$1,551
Medicare patients
14
Services billed
14

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acyclovir17$351
Alcohol PadsAlcohol Antiseptic Pads13$327
Prochlorperazine Maleate13$278
Ondansetron Hcl34$220
Gabapentin11$117
Tramadol Hcl14$50
Single Use SwabAlcohol Antiseptic Pads19$33
Prednisone13$30

Paid to pharmacies, not to this prescriber.

Other family in Rancho Mirage

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →